Skip to content
AusGrant
Federal Closing soon GRANTS-GOV-362250

DoW Lung Cancer Translational Research Award

Defense Health Agency Contracting Activity - DHACA (DOD) · Competitive grant · Science & Technology

At a glance

DoW Lung Cancer Translational Research Award is a federal competitive grant from Defense Health Agency Contracting Activity - DHACA for the science & technology sector. Funding is up to $2K. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The application deadline is September 2, 2026. Apply via the official listing at www.grants.gov.

Amount
Up to $2K
Deadline
Sep 2, 2026
Type
Competitive
Status
Closing soon

About this program

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

How to apply

Apply through Grants.gov using funding opportunity number HT942526LCRPTRA. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source